<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerNicholas C. Turner, Alan Ashworth, Andrew Tutt et al.|Cancer Research|2010Cited by 740
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special typeBritta Weigelt, Jorge S. Reis‐Filho, Felipe C. Geyer et al.|The Journal of Pathology|2009Cited by 237
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour modelsLorenzo Melchor, Matthew J. Smalley, Gemma Molyneux et al.|The Journal of Pathology|2014Cited by 59
Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype‐matched ductal and lobular carcinomasMaría Ángeles López‐García, Britta Weigelt, Felipe C. Geyer et al.|The Journal of Pathology|2010Cited by 40
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biologyFelipe C. Geyer, Giovanni Tallini, Dario de Biase et al.|Breast Cancer Research and Treatment|2011Cited by 22